1. Home
  2. CBLL vs DAWN Comparison

CBLL vs DAWN Comparison

Compare CBLL & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBLL
  • DAWN
  • Stock Information
  • Founded
  • CBLL 2014
  • DAWN 2018
  • Country
  • CBLL United States
  • DAWN United States
  • Employees
  • CBLL N/A
  • DAWN N/A
  • Industry
  • CBLL
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CBLL
  • DAWN Health Care
  • Exchange
  • CBLL Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • CBLL 710.2M
  • DAWN 658.9M
  • IPO Year
  • CBLL 2024
  • DAWN 2021
  • Fundamental
  • Price
  • CBLL $14.14
  • DAWN $6.65
  • Analyst Decision
  • CBLL Strong Buy
  • DAWN Strong Buy
  • Analyst Count
  • CBLL 6
  • DAWN 6
  • Target Price
  • CBLL $33.00
  • DAWN $30.17
  • AVG Volume (30 Days)
  • CBLL 209.0K
  • DAWN 1.3M
  • Earning Date
  • CBLL 08-05-2025
  • DAWN 08-05-2025
  • Dividend Yield
  • CBLL N/A
  • DAWN N/A
  • EPS Growth
  • CBLL N/A
  • DAWN N/A
  • EPS
  • CBLL N/A
  • DAWN N/A
  • Revenue
  • CBLL $71,535,000.00
  • DAWN $161,922,000.00
  • Revenue This Year
  • CBLL $33.98
  • DAWN $16.42
  • Revenue Next Year
  • CBLL $28.82
  • DAWN $47.52
  • P/E Ratio
  • CBLL N/A
  • DAWN N/A
  • Revenue Growth
  • CBLL 44.86
  • DAWN N/A
  • 52 Week Low
  • CBLL $10.01
  • DAWN $6.08
  • 52 Week High
  • CBLL $32.75
  • DAWN $16.76
  • Technical
  • Relative Strength Index (RSI)
  • CBLL N/A
  • DAWN 46.52
  • Support Level
  • CBLL N/A
  • DAWN $6.32
  • Resistance Level
  • CBLL N/A
  • DAWN $7.18
  • Average True Range (ATR)
  • CBLL 0.00
  • DAWN 0.29
  • MACD
  • CBLL 0.00
  • DAWN -0.01
  • Stochastic Oscillator
  • CBLL 0.00
  • DAWN 30.56

About CBLL CeriBell Inc. Common Stock

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: